Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year  | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| HOSPIRA, INC. | Pfizer | pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $132,300 |
| Pfizer Pharmaceuticals Ltd. | Pfizer | pharmaceuticals | water pollution violation | 2004 | EPA | $20,025 |
| Watson Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | water pollution violation | 2004 | EPA | $20,000 |
| Wyeth Ayerst Pharmaceuticals | Pfizer | pharmaceuticals | hazardous waste violation | 2004 | EPA | $37,000 |
| PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
| ABBOTT LABS-N CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2004 | EPA | $162,595 |
| MALLINCKRODT, INC | Mallinckrodt | pharmaceuticals | air pollution violation | 2004 | EPA | $80,160 |
| Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | SEC | $1,000,000 |
| Therasense, Inc. | Abbott Laboratories | pharmaceuticals | labor relations violation | 2003 | NLRB | $236,827 |
| SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2003 | MO-AG | $70,000 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2003 | PA-ENV | $8,978 |
| ANIKA THERAPEUTICS INC | Anika Therapeutics | pharmaceuticals | environmental violation | 2003 | MA-ENV | $15,500 |
| BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $28,000 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $8,000 |
| ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $14,200 |
| ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $14,000 |
| American BioScience Inc. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
| Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
| GENENTECH | Roche | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $11,240 |
| ELAN PHARMACEUTICALS INC. | Perrigo | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $7,125 |
| PHIBRO-TECH INC | Phibro Animal Health | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $7,560 |
| NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $5,610 |
| PLIVA, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $19,775 |
| Lilly Del Caribe, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2003 | EPA | $68,992 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2003 | EPA | $61,158 |
| research organics | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2003 | EPA | $159,672 |
| Pfizer Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
| Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2002 | BIS | $1,760,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | railroad safety violation | 2002 | FRA | $11,250 |
| Schering-Plough Corporation | Merck | pharmaceuticals | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Eli Lilly & Co. | Eli Lilly | pharmaceuticals | privacy violation | 2002 | MULTI-AG | $160,000 |
| General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Alpharma Animal Health Division | Zoetis | pharmaceuticals | hazardous waste violation | 2002 | AR-ENV | $9,394 |
| ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2002 | IN-ENV | $17,000 |
| AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2002 | MA-ENV | $15,000 |
| HOFFMAN LAROCHE INC | Roche | pharmaceuticals | hazardous waste violation | 2002 | NJ-ENV | $5,000 |
| PHARMACIA CORP | Pfizer | pharmaceuticals | air pollution violation | 2002 | NJ-ENV | $8,625 |
| PLIVA INC | Teva Pharmaceutical Industries | pharmaceuticals | water pollution violation | 2002 | NJ-ENV | $41,350 |
| E. Merck KG | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $50,000,000 |
| TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $15,300 |
| AMPHASTAR PHARMACEUTICALS INC | Amphastar Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $18,500 |
| ROCHE MOLECULAR SYSTEMS INC | Roche | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $9,225 |
| SHIRE CORP | Takeda Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $8,100 |
| BARR LABORATORIES, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $14,000 |
| IVAX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $15,120 |
| SEARLE LTD | Pfizer | pharmaceuticals | hazardous waste violation | 2002 | EPA | $95,000 |
| Schering Plough Products | Merck | pharmaceuticals | hazardous waste violation | 2002 | EPA | $49,000 |
| Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
| IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $10,001 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | fraud | 2001 | USAO | $5,600,000 |
| Roussel Uclaf S.A. | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
| Seagen Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $29,974 |
| Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| Knoll Pharmaceuticals | AbbVie | pharmaceuticals | consumer protection violation | 2001 | AR-AG | $826,957 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | AR-AG | $525,780 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
| Alpharma Animal Health Division | Zoetis | pharmaceuticals | hazardous waste violation | 2001 | AR-ENV | $80,000 |
| ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2001 | FL-DEP | $15,000 |
| ROCHE DIAGNOSTICS CORP | Roche | pharmaceuticals | air pollution violation | 2001 | IN-ENV | $13,200 |
| BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2001 | NJ-ENV | $6,000 |
| UCB Chemicals Corporation | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
| DURAMED PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $7,000 |
| ALPHARMA ANIMAL HEALTH COMPANY | Zoetis | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $18,300 |
| PHARMAVITE CORP | Otsuka Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $18,300 |
| KING PHARMACEUTICALS | Pfizer | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $7,200 |
| ALPHARMA ANIMAL HEALTH COMPANY | Zoetis | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $25,600 |
| HI TECH PHARMACAL CO., INC. | Akorn Inc. | pharmaceuticals | water pollution violation | 2001 | EPA | $20,500 |
| PHARMACIA & UPJOHN CARIBE | Pfizer | pharmaceuticals | environmental violation | 2001 | EPA | $27,168 |
| SCHERING-PLOUGH PRODUCTS LLC | Merck | pharmaceuticals | hazardous waste violation | 2001 | EPA | $54,100 |
| UCB CHEMICAL CORPORATION | UCB | pharmaceuticals | environmental violation | 2001 | EPA | $6,824 |
| LAFAYETTE PHARMACEUTICALS, INC. | Mallinckrodt | pharmaceuticals | environmental violation | 2001 | EPA | $17,600 |
| Mylan Laboratories, Inc. | Viatris | pharmaceuticals | consumer protection violation | 2000 | FTC | $100,000,000 |
| Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
| Mallinckrodt, Inc. | Mallinckrodt | pharmaceuticals | nuclear safety violation | 2000 | NRC | $125,000 |
| CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
| Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
